Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Patient Access Pulse by Pelitas: Engaging iPAS Version 10 for Interoperability

As healthcare revolutionizes to meet interoperability needs, so does the technology. iPAS Version 10 (v10) is one data management tool driving the transformation. Kristine Anderson, Vice President of Solutions Management at Pelitas, and Tracy Eckerman, Associate Vice President of Technical Solutions Management, met with host Tyler Kern to explain exactly how. The pandemic accelerated tech…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

As healthcare revolutionizes to meet interoperability needs, so does the technology. iPAS Version 10 (v10) is one data management tool driving the transformation. Kristine Anderson, Vice President of Solutions Management at Pelitas, and Tracy Eckerman, Associate Vice President of Technical Solutions Management, met with host Tyler Kern to explain exactly how.

The pandemic accelerated tech too creation to meet various healthcare needs, such as patient access, telehealth, and virtual intake. The virtual intake medicine suite was one of the first products iPAS v10 launched; it involves the patient so they are an active participant in their care management.

While helpful, the variety of tools has presented challenges, creating siloed data if not properly integrated. “Interoperability is going to be absolutely critical in this next year for being able to leverage all of those tools,” explained Eckerman. Next year, the plan is to deepen integration opportunities. “It’s really going to be exciting to build on what we’ve already done and take the product to the next level,” said Anderson.

Anderson provided the definition of data management, stating that it is “the practice of collecting, keeping, and using data securely, cost-effectively, and efficiently.’” Collecting data seems basic, but what data needs to be collected varies by patient. It must be stored in the EHR without extra steps and used effectively to easily manipulated reports that track trends.

Looking forward, where does the ultimate answer in healthcare data management lie? “Digital transformation maturity doesn’t happen overnight but getting the right data in the right system and working with the right people will drive organizational transformation and help our clients improve their business processes in patient access,” Eckerman summarized.

Head to pelitas.com for insight into iPAS v10 and subscribe to Patient Access Pulse to keep up with the latest topics

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Who's Really Running Healthcare? (When Physicians No Longer Have a Voice) - Dr. Krishna Vedala

Physician burnout stems not just from workload but from loss of meaningful voice in healthcare organizations. Dr. Krishna Vedala discusses how primary care is mismanaged as a procedural business, how AI should free physicians from administrative work rather than replace them, and why physicians may need collective representation to restore trust between clinicians and administrators.

  • 01Physicians increasingly lack meaningful participation in organizational decisions, despite being closest to patients and responsible for care delivery.
  • 02Primary care requires complex, nuanced decision-making but is often managed with productivity expectations designed for procedural specialties, pushing work home and some physicians toward breaking point.
  • 03AI's highest value is reducing administrative burden and documentation so physicians have more time with patients, not replacing clinical judgment or human relationships.

Sep 8, 2026

MRI segmentation models can now label 80 structures, but deployment is the hard part

MRI segmentation models can now label 80 structures. TotalSegmentator MRI is an nnU-Net model that provides rapid segmentation of all major organs across all MRI sequences, according to Radiology Business. For health systems, deployment is the hard part.

  • 01The spread between 0.97 Dice on lungs and 0.54 on portal and splenic veins in MRSegmentator is the real operational story: enterprises need confidence flags and escalation paths, not a single headline score.
  • 02Hospitals planning radiation oncology and neuro volumetry programs can treat segmentation speedups as capacity gains only if downstream steps, contour review, dose planning inputs, and reporting templates, are standardized.

Sep 8, 2026

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512